Accession Number: | 0000899243-19-024172 |
Date: | 2019-09-20 |
Issuer: | CLOVIS ONCOLOGY, INC. (CLVS) |
Original Submission Date: |
IVERS-READ GILLIAN C
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER, CO 80301
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-20 | M | 1,875 | a | $0.00 | 194,346 | direct | ||
COMMON STOCK | 2019-09-20 | S | 837 | d | $4.80 | 193,509 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2019-09-20 | deemed execution date | M | 1,875 (d) | common stock 1,875 | $0.00 | 9,375 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents the right to receive one share of common stock. |
f2 | represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the restricted stock units listed in table ii. this sale does not represent a discretionary trade by the reporting person. |
f3 | this transaction was executed in multiple trades at prices ranging from $4.80 to $4.86. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f4 | on december 19, 2016, the reporting person was granted 30,000 restricted stock units. 25% of such restricted stock units vested on december 19, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date. |